Breast Cancer Therapy
Study data from Oncology Center provide new insights into breast cancer therapy
Published in Biotech Law Weekly, January 19th, 2007
Research findings, "HER2-positive breast cancer brain metastases: multiple responses to systemic chemotherapy and trastuzumab--a case report," are discussed in a new report. According to a study from Bristol, the United Kingdom, "Brain metastases from metastatic breast cancer typically occur in 10-15% of patients and are associated with survival of 3-6 months. Recent series have shown that women with HER2-positive metastatic breast cancer receiving the drug trastuzumab develop brain metastases more frequently than this, but also that continuation of trastuzumab after diagnosis of brain metastases in such patients is associated with extended survival."
"Authors have...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2007-01-19)
More Articles from Biotech Law Weekly
- Awards
Neuropharma receives Frost & Sullivan International Excellence in Technology award - Business & Finance
Genmab discloses details of the issue of shares to GlaxoSmithKline - Business Update
Advancis closes private placement of common equity, files application for Pulsys - Business Update
Analytical Spectral Devices launches portable drug anti-counterfeiting technology - Business Update
Anchen announces approval of generic version of Wellbutrin XL - Business Update
Nycomed receives E.U. and U.S. antitrust clearances for acquisition of Altana Pharma - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
